Complete News World

Valneva will attend investor conferences in the US and France in early 2023

Valneva will attend investor conferences in the US and France in early 2023

12/21/2022, 642 characters

Valneva in the 41st period. Annual JP Morgan Healthcare Conference from 9 to 12 January 2023 in San Francisco, USA and Oddo BHF Forum from 5 to 6 January 2023 in Lyon, France.

Valneva’s CEO and CFO will specifically discuss the company’s current vaccine pipeline and commercial products, as well as highlight Valneva’s key near- and mid-term value drivers, including Lyme disease vaccine candidate VLA15 (Phase 3, in collaboration with Pfizer) and chikungunya virus. Vaccine candidate VLA1553 (rolling filing pending).

BSN Podcasts

Christian Trastevere: Vienna Stock Exchange Chat

Vienna Stock Exchange Chat S3/72: Do&Co, method; Associates in Spotify, CPI Property & GameStop, European Lithium, Jungbunzlauer-Aus

Photo credit

1. Valneva, Laboratory, Vaccine, Credit: Valneva , (© Submitter) >> Open at

Stocks on the radar:UBM, CA immo, Cemprite, Zumdobel, Vienna Airport, S Reality, The first group, Peer Mobility, SPO, RBI, OMV, Polytech Group, A.M.S, AT&S, Clean Energy, EVN, Lensing, Linz Textile Holding, Rosenbauer, Vienna Private Bank, Warimpex, Oberbank AG stem, Adigo Bank.

Random partners

Wikifolio went online in 2012 and today is Europe’s leading online platform with trading strategies for all investors who value smart investments. Wikifolio traders, including full-time investors, successful entrepreneurs, experts in specific industries, asset managers or financial authors, share their trading ideas in sample portfolios on Wikifolios. You can follow these easily and directly – with an investment in a relevant, protected Wikifolio certificate.

>> Visit over 65 partners

See also  NBA: Dennis Schroder to fly to US over weekend

Valneva, laboratory, vaccine, credit: Valneva, (© sender)